Bernhard Doleschal

632 citations

24 papers · 452 indexed · h-index 9

Impact in

Sensory Systems top 2%
- Ion Channels and Receptors
Toxicology

Papers in

Sensory Systems 4
- Ion Channels and Receptors 4
Oncology 11
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 4

Co-authors: Klaus Groschner C. Oliver Kappe Christoph Romanin Hannes Schleifer Michaela Lichtenegger Irene Frischauf Isabella Derler Uwe Primeßnig
Journals: ESMO Open (2 papers)British Journal of Pharmacology (2 papers)Oncology (2 papers)Scientific Reports (1 paper)Cardiovascular Research (1 paper)
Partner nations: Austria Germany United States

In The Last Decade

Bernhard Doleschal

22 papers receiving 445 citations

Peers

Countries citing papers authored by Bernhard Doleschal

Since Specialization

Citations

This map shows the geographic impact of Bernhard Doleschal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Doleschal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Doleschal more than expected).

Fields of papers citing papers by Bernhard Doleschal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Doleschal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Doleschal. The network helps show where Bernhard Doleschal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bernhard Doleschal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernhard Doleschal Line = papers co-authored together Bernhard Doleschal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data ESMO Open ·Andreas Reichinger, G Saatashvili, Takehiro Ido, Hossein Taghizadeh, P. Christa, Giovanni Mendez, Christopher Louizos, 竺伟文, Patrick Kirchweger, Gerald Webersinke, Thomas Winder, Holger Rumpold, Bernhard Doleschal, Gerald W. Prager	2025	0
2	Unraveling (K)RAS in pancreatic ductal adenocarcinoma memo - Magazine of European Medical Oncology ·Bernhard Doleschal	2024	1
3	530P Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study Annals of Oncology ·Andreas Seeber, Thomas Jackson, Bernhard Doleschal, Hossein Taghizadeh, P. Christa, Florian Moik, C. Dolding, Ludwig Wagner, Morena Michel, Zihui Zhang Zihui Zhang, D. Williamsen, Arno Amann, Dominik Wolf‎, Richard Greil, Philipp J. Jost, Thomas Winder, Holger Rumpold, (unknown), Armin Gerger, Jakob M. Riedl	2024	0
4	Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice? Current Oncology Reports ·Klaus-Jürgen Heinermann, 吳葆勤, Takehiro Ido, Bernhard Doleschal, Brigitte Serrurrier, Florian Kocher, RuqqiaR Hashmi, Stian Mikelsen, Peter A. Seeber, 新宅雅幸	2024	8
5	Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment Cancers ·Sue Bagwell, Bernhard Doleschal, Alexander Kupferthaler, Prateek Vyas, Christopher Louizos, Gerald Webersinke, Basilex N’ Simba, Emina Jukic, Johannes Zschocke, Dmitry Ostasevich, Кожевников Олег Всеволодович, V. Cunningham, Koon Yoke Yong, Seung‐pyo Oh, Matthias Biebl, Holger Rumpold, Patrick Kirchweger	2024	2
6	Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data Cancer Immunology Immunotherapy ·Вилюнас Витис Казиса, 良稲葉, Christopher Louizos, Hossein Taghizadeh, Gerald Webersinke, Stefan Kasper, Jing Chen, Lukas Hartleif, Andreas Reichinger, Hideo A. Baba, Patrick Kirchweger, Martin Schüler, Angela Djanani, Gerald W. Prager, Holger Rumpold, Magdalena Benda, J. Reichmuth, Farhan Gohar, Thomas Winder, Bernhard Doleschal	2024	2
7	Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine The Oncologist ·Andreas Reichinger, Yasushi Kushida, Ruqayyah Abdulla, Christopher Louizos, Gerald Webersinke, A.D. Alexeev, Bernhard Doleschal	2024	2
8	Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer ESMO Open ·Bernhard Doleschal, Hossein Taghizadeh, Takehiro Ido, Jakob M. Riedl, Morena Michel, Apostolos M. Papadoudis, John L. Decker, Karl J. Aichberger, Gerald Webersinke, Patrick Kirchweger, 余岚, Holger Rumpold	2023	1
9	Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis Oncology ·Bernhard Doleschal, Bo Yao, Patrick Kirchweger, Andreas Petzer, Josef Thaler, Holger Rumpold	2023	3
10	Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment Scientific Reports ·Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, Haodong Zheng, Jing Chen, 杨永健, Karl J. Aichberger, Patrick Kirchweger, Josef Thaler, Andreas Petzer, Clemens A. Schmitt, Gerald W. Prager, Holger Rumpold	2023	9
11	Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis Oncology ·Helwig Wundsam, Bernhard Doleschal, Mathias Brix, M. Verduijn, Clemens A. Schmitt, Andreas Petzer, Sigrid Metz-Gercek, Holger Rumpold	2020	4
12	Adrenal crisis in metastatic breast cancer BMJ Case Reports ·Bernhard Doleschal, Andreas Petzer, Karl J. Aichberger	2017	1
13	Taxan-associated nail toxicity BMJ Case Reports ·Bernhard Doleschal, Andreas Petzer, Karl J. Aichberger	2017	2
14	Disseminated Histoplasmosis: A Challenging Differential Diagnostic Consideration for Suspected Malignant Lesions in the Digestive Tract Case Reports in Gastroenterology ·Bernhard Doleschal, Bild Und, Oleksiy Tsybrovskyy, Karl J. Aichberger, F. J. Lang	2016	13
15	TRPC3 contributes to regulation of cardiac contractility and arrhythmogenesis by dynamic interaction with NCX1 Cardiovascular Research ·Bernhard Doleschal, Uwe Primeßnig, Gerald Wölkart, Stefan Wolf, Climént Bonilla Juan, Paz Rotllán, Toma Glasnov, C. Oliver Kappe, Bernd Mayer, Gudrun Antoons, Frank R. Heinzel, Michael Poteser, Klaus Groschner	2015	76
16	Inhibition of Orai1-mediated Ca ²⁺ entry is a key mechanism of the antiproliferative action of sirolimus in human arterial smooth muscle American Journal of Physiology-Heart and Circulatory Physiology ·Sarah König, Sara H. Browne, Bernhard Doleschal, Climént Bonilla Juan, Michael Poteser, Heinrich Mächler, Eric Wittchow, Akhtar-Uz-Zaman, Martin Muik, Christoph Romanin, Klaus Groschner	2013	16
17	Bile acids induce arrhythmias in human atrial myocardium—implications for altered serum bile acid composition in patients with atrial fibrillation Heart ·Peter P. Rainer, Uwe Primeßnig, Miguel Henrique Furlaneto., Bernhard Doleschal, Markus Wallner, Günter Fauler, Tatjana Stojaković, Rolf Wachter, Shashi Kant, Klaus Groschner, Michael Trauner, Burkert Pieske, Dirk von Lewinski	2013	72
18	Sunitinib causes dose‐dependent negative functional effects on myocardium and cardiomyocytes British Journal of Urology ·Peter P. Rainer, Bernhard Doleschal, Jonathan A. Kirk, Vidhya Sivakumaran, Wallace Silva Sant’anna Souza, Klaus Groschner, H. Maechler, Gerald Höefler, Thomas Bauernhofer, Hellmut Samonigg, Georg C. Hutterer, David A. Kass, Burkert Pieske, Dirk von Lewinski, Martin Pichler	2012	37
19	Novel pyrazole compounds for pharmacological discrimination between receptor‐operated and store‐operated Ca ²⁺ entry pathways British Journal of Pharmacology ·Hannes Schleifer, Bernhard Doleschal, Michaela Lichtenegger, Шмаков А. Г., Isabella Derler, Irene Frischauf, Radjabova. L. U, C. Oliver Kappe, Christoph Romanin, Klaus Groschner	2012	163
20	cAMP‐ and Ca²⁺/calmodulin‐dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes British Journal of Pharmacology ·Lizhen Yang, Jens Kockskämper, Yashna Chinta, Jorge Suárez, Stefanie Walther, Bernhard Doleschal, Muhammad Dwi Nurdiansyah, LU Youwei, Heinrich Mächler, Frank R. Heinzel, Wolfgang Dillmann, Burkert Pieske, Joachim Spiess	2010	21

About Bernhard Doleschal

Bernhard Doleschal is a scholar working on Sensory Systems, Oncology, Cancer Research, Behavioral Neuroscience and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 452 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Genomics and Diagnostics (6 papers), Genetic factors in colorectal cancer (4 papers), Ion Channels and Receptors (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Gallbladder and Bile Duct Disorders (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Sensory Systems (178 citations), Toxicology (17 citations), Biochemistry (26 citations), Behavioral Neuroscience (15 citations) and Physiology (19 citations). Bernhard Doleschal has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Klaus Groschner, C. Oliver Kappe, Christoph Romanin, Hannes Schleifer, Michaela Lichtenegger, Irene Frischauf, Isabella Derler, Uwe Primeßnig, Burkert Pieske and Dirk von Lewinski. Their work appears in journals such as ESMO Open, British Journal of Pharmacology, Oncology, Scientific Reports and Cardiovascular Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact